ARTICLE | Company News
Anadis, ImmuCell deal
August 13, 2007 7:00 AM UTC
ANX and veterinary company ICCC signed an exclusive, royalty-bearing cross-license related to their polyclonal antibody technologies. ANX will receive rights to ICCC's OTC Nisin antimicrobial peptide ...